0000000000212087

AUTHOR

Eva Cine

showing 2 related works from this author

H.Pylori infekcijas un atrofiska gastrīta izplatība Latvijā

2012

H.pylori infekcija un atrofisks gastrīts ir saistīts ar paaugstinātu kuņģa vēža risku. Pētījuma mērķis bija seroloģiski noteikt H.pylori un atrofiska gastrīta izplatību Latvijā. Metodes. Darbs bija veikts kā viena sadaļa no Latvijas iedzīvotāju šķērsgriezuma pētījuma. Plazmas paraugā tika noteiktas H.pylori IgG antivielas (Mikrogen Diagnostik, Vācija, ar robežvērtību 24 U/ml) un pepsinogēna I, pepsinogēna II līmenis (Eiken Chemical Co., Japāna, ar robežvērtībām PgI ≤ 70 ng/ml un attiecība PgI/PgII ≤ 3, kas parāda kopējo kuņģa atrofiju un PgI ≤ 30 ng/ml un attiecība PgI/PgII ≤ 2, kas parāda smagu kuņģa atrofiju). Rezultāti. Pētījuma ietvaros tika savākti 3564 asins seruma paraugi (1218 vīrie…

Medicīna
researchProduct

Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.

2012

Helicobacter pylori infection and atrophic gastritis are related to an increased risk for gastric cancer. There is a decrease in global H. pylori prevalence. We analyzed the prevalence of H. pylori infection in Latvia by the plasma IgG test and the presence of atrophy by means of pepsinogen testing.This subanalysis was carried out on a randomly selected cross-sectional sample of a general population of adults to access cardiovascular risk factors. Plasma samples were screened for H. pylori IgG (cutoff value 24 U/ml), and pepsinogens (Pg) I and II. Pg cutoff values of PgI/PgII ≤ 3 and PgI ≤ 70 ng/ml were used to assess the prevalence of atrophy of any grade and PgI/PgII ≤ 2 and PgI ≤ 30 ng/m…

AdultGastritis AtrophicMalemedicine.medical_specialtyHelicobacter pylori infectionAdolescentCross-sectional studyAtrophic gastritisGastroenterologySeverity of Illness IndexHelicobacter InfectionsYoung AdultAtrophySex FactorsPredictive Value of TestsRisk FactorsStomach NeoplasmsInternal medicinePepsinogen AmedicinePepsinogen CPrevalenceHumansYoung adultAgedAged 80 and overChi-Square DistributionHepatologybiologyHelicobacter pyloribusiness.industryGastroenterologyAge FactorsCancerMiddle Agedbacterial infections and mycosesmedicine.diseaseAntibodies BacterialLatviaCross-Sectional Studiesbiology.proteinLinear ModelsFemaleGastritismedicine.symptomAntibodybusinessPrecancerous ConditionsBiomarkersEuropean journal of gastroenterologyhepatology
researchProduct